Grade My Investments
HomeFree Stock Grades › GRDN

Guardian Pharmacy Services, Inc. (GRDN) Stock Grade

GRDN · Healthcare

A+
Grade updated: July 18, 2026
Computed by the GradeMyInvestments scoring model from revenue growth, profitability, balance-sheet strength, and analyst targets.
Market Cap
$1.9B
P/E Ratio
38.1
Revenue Growth (YoY)
+17.9%
Net Margin
3.4%
Return on Equity
23.9%
Dividend Yield
None

About Guardian Pharmacy Services, Inc.'s fundamentals

Guardian Pharmacy Services generates strong revenue growth at 17.9% year-over-year, supported by a healthy return on equity of 23.9% that indicates efficient capital deployment. However, the company operates with a modest net profit margin of 3.4%, typical for pharmaceutical distribution businesses with thin margins. The valuation reflects growth expectations, with a P/E ratio of 38.1 considerably higher than many peers in the distribution space. The company does not currently pay a dividend, reinvesting earnings back into operations.

Track GRDN free — no credit card required. Live grade + monthly AI report →